| New Disease | Relapse | Remission | Control | Group p value | ND vs Rel | ND vs Rem | ND vs Con | Rel Vs Rem | Rel Vs Con | Rem vs Con |
---|---|---|---|---|---|---|---|---|---|---|---|
Sample size (N) | 7 | 19 | 20 | 46 | Â | Â | Â | Â | Â | Â | Â |
PT (s) (11 -16) | |||||||||||
 Median | 12.0 | 12.0 | 12.0 | 13.0 | 0.024* |  > 0.05 |  > 0.05 |  > 0.05 |  > 0.05 |  > 0.05 |  > 0.05 |
 IQR | 12.0 – 15.0 | 10.0 -13.0 | 11.0 – 13.0 | 12.0 – 14.0 |  |  |  |  |  |  |  |
INR (0.8 -1.2) | |||||||||||
 Median | 1.1 | 0.9 | 0.9 | 1.0 | 0.009* |  > 0.05 |  > 0.05 |  > 0.05 |  > 0.05 |  > 0.05 |  > 0.05 |
 IQR | 0.9 – 1.2 | 0.8 – 1.0 | 0.8 – 1.0 | 0.9 -1.1 |  |  |  |  |  |  |  |
Platelet Count ( x103cells/mm3) (150 -400) | |||||||||||
 Median | 432 | 259 | 233 | 235 | 0.047* |  > 0.05 |  > 0.05 | 0.01* |  > 0.05 |  > 0.05 |  > 0.05 |
 IQR | 268—512 | 165—301 | 181—274 | 197—278 |  |  |  |  |  |  |  |